Federal Register / Vol. 73, No. 12 / Thursday, January 17, 2008 / Notices 3257 

site and call the appropriate advisory 

committee hot line/phone line to learn 

about possible modifications before 

coming to the meeting. 

Agenda: On both days, the committee 

will discuss product development and 

clinical trial design for both mild/ 

moderate and moderate/severe 

community acquired pneumonia (CAP). 

A primary objective for committee 

deliberations is to discuss issues 

relating to the identification of an 

appropriate noninferiority margin for 

active controlled trials. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ohrms/ 

dockets/ac/acmenu.htm, click on the 

year 2008 and scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before March 18, 2008. 

Oral presentations from the public will 

be scheduled between approximately 12 

noon and 1 p.m. on April 2, 2008. Those 

desiring to make formal oral 

presentations should notify the contact 

person and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation on or before March 

10, 2008. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by March 11, 2008. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Sohail 

Mosaddegh at least 7 days in advance of 

the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/oc/advisory/ 

default.htm for procedures on public 

conduct during advisory committee 

meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: January 7, 2008. 

Randall W. Lutter, 

Deputy Commissioner for Policy. 

[FR Doc. E8–814 Filed 1–16–08; 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Advisory Committee on Rural 

Health and Human Services; Notice of 

Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Public Law 92–463), notice is hereby 

given that the following committee will 

convene its fifty-eighth meeting. 

Name: National Advisory Committee on 

Rural Health and Human Services. 

Dates and Times: February 20, 2008, 9 

a.m.–5 p.m., February 21, 2008, 9 a.m.–4:30 

p.m., February 22, 2008, 8:30 a.m.–10:30 a.m. 

Place: The Sofitel Lafayette Square, 806 

15th Street, NW., Washington, DC 20005, 

Phone: 202–730–8800. 

Status: The meeting will be open to the 

public. 

Purpose: The National Advisory 

Committee on Rural Health and Human 

Services provides advice and 

recommendations to the Secretary with 

respect to the delivery, research, 

development and administration of health 

and human services in rural areas. 

Agenda: Wednesday morning, February 20, 

at 9 a.m., the meeting will be called to order 

by the Chairperson of the Committee, the 

Honorable David Beasley. Elizabeth M. Duke, 

Administrator of the Health Resources and 

Services Administration, has been invited to 

give opening remarks. The first presentation 

will be by Joan Ohl, Commissioner, 

Administration on Children, Youth and 

Families in the Administration for Children 

and Families. Other invited speakers are Jan 

McCarthy and Joyce Sabien, Child Protective 

Services and Mental Health Researchers, 

Georgetown University, and Thomas M. 

Dowd, Deputy Assistant Secretary, 

Employment and Training Administration, 

U.S. Department of Labor. The presentations 

will be followed by a Committee discussion. 

The Wednesday meeting will close at 5 p.m. 

Thursday morning, February 21, at 9 a.m., 

the Committee will open with a presentation 

by Dr. Bob Berenson with The Urban 

Institute. This will be followed by a 

presentation from Cheryl Sparks with The 

Rural Community College Alliance. The 

Committee will break into Subcommittee 

format to discuss the topics presented and 

reconvene at 3 p.m. for a discussion of the 

Committee as a whole. The Thursday 

meeting will close at 4:30 p.m. 

The final session will be convened Friday 

morning, February 22, at 8:30 a.m. There will 

be a review of the meeting and action items 

will be developed for the Committee 

members and staff. The Committee will draft 

the letter to the Secretary and discuss the 

June meeting. The meeting will be adjourned 

at 10:30 a.m. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requiring information regarding 

the Committee should contact Jennifer 

Chang, MPH, Executive Secretary, 

National Advisory Committee on Rural 

Health and Human Services, Health 

Resources and Services Administration, 

Parklawn Building, Room 9A–55, 5600 

Fishers Lane, Rockville, MD 20857, 

Telephone (301) 443–0835, Fax (301) 

443–2803. 

Persons interested in attending any 

portion of the meeting should contact 

Michele Pray-Gibson, Office of Rural 

Health Policy (ORHP), Telephone (301) 

443–0835. The Committee meeting 

agenda will be posted on ORHP’s Web 

site: http://www.ruralhealth.hrsa.gov. 

Dated: January 10, 2008. 

Alexandra Huttinger, 

Acting Director, Division of Policy Review 

and Coordination. 

[FR Doc. E8–836 Filed 1–16–08; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: March 3–4, 2008. 

Time: March 3, 2008, 8 a.m. to 6 p.m. 

Agenda: Director’s Report: Ongoing and 

New Business; Reports of Program Review 

Group(s); and Budget Presentation; Reports of 

mstockstill on PROD1PC66 with NOTICES

3258 Federal Register / Vol. 73, No. 12 / Thursday, January 17, 2008 / Notices 

Special Initiatives; RFA and RFP Concept 

Reviews; and Scientific Presentations. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th Floor, 

Conference Room 10, Bethesda, MD 20892. 

Time: March 4, 2008, 8:30 a.m. to 12 p.m. 

Agenda: Reports of Special Initiatives; RFA 

and RFP Concept Reviews; and Scientific 

Presentations. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th Floor, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Paulette S. Gray, PhD., 

Executive Secretary, Director, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Rm. 8001, 

Bethesda, MD 20892, 301–496–5147, 

grayp@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/bsa.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Treatment Research; 93.396, 

Cancer Biology Research; 93.397, Cancer 

Centers Support; 93.398, Cancer Research 

Manpower; 93.399, Cancer Control, National 

Institutes of Health, HHS) 

Dated: January 9, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–133 Filed 1–16–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Cellular & 

Tissue Biology (SEP). 

Date: February 6–8, 2008. 

Time: 5 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Shakeel Ahmad, PhD, 

Scientific Review Administrator, Research 

Programs Review Branch, National Cancer 

Institute, Division of Extramural Activities, 

6116 Executive Boulevard, Room 8137, 

Bethesda, MD 20892–8328, (301) 594–0114, 

ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Clinical 

Studies SEP. 

Date: February 13–14, 2008. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Majed M. Hamawy, PhD, 

MBA., Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 8135, Bethesda, MD 20892, (301) 594–

5659, mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group. 

Date: February 26–27, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Arlington, 1325 Wilson 

Boulevard, Arlington, VA 22209. 

Contact Person: Lynn M. Amende, PhD, 

Scientific Review Administrator, Research 

Programs and Training Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, 6116 Executive Blvd., Room 

8105, Bethesda, MD 20892, (301) 451–4759, 

amendel@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group. Subcommittee 

I—Career Development. 

Date: February 26–27, 2008. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Arlington, 1325 Wilson 

Boulevard, Arlington, VA 22209. 

Contact Person: Robert Bird, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Blvd., Room 8113, 

MSC 8328, Bethesda, MD 20892–8328, 301–

496–7978, birdr@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Ruth L. 

Kirschstein National Research Service Award 

(T32). 

Date: February 26, 2008. 

Time: 5 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Arlington, 1325 Wilson 

Boulevard, Arlington, VA 22209. 

Contact Person: Robert Bird, PhD., 

Scientific Review Administrator, Resources 

and Training Review Branch, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Blvd., Room 8113, 

MSC 8328, Bethesda, MD 20892–8328, 301–

496–7978, birdr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: January 9, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–134 Filed 0–16–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Initial Review Group, 

Clinical Research Review Committee, CTSA. 

Date: February 5–6, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 

Double Tree Name Changed, 1750 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Mohan Viswanathan, PhD, 

Deputy Director, National Center for 

Research Resources, or, National Institutes of 

mstockstill on PROD1PC66 with NOTICES